The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure.
Fiche publication
Date publication
mars 2021
Journal
Journal of cachexia, sarcopenia and muscle
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Pandhi P, Streng KW, Anker SD, Cleland JG, Damman K, Dickstein K, Pellicori P, Lang CC, Ng L, Samani NJ, Zannad F, Metra M, Rossignol P, Filippatos G, van Veldhuisen DJ, Voors AA, Ter Maaten JM
Lien Pubmed
Résumé
Muscle wasting and unintentional weight loss (cachexia) have been associated with worse outcomes in heart failure (HF), but timely identification of these adverse phenomena is difficult. Spot urinary creatinine may be an easily accessible marker to assess muscle loss and cachexia. This study investigated the association of urinary creatinine with body composition changes and outcomes in patients with new-onset or worsening HF (WHF).
Mots clés
Acute heart failure, Muscle wasting, Urinary creatinine, Weight loss
Référence
J Cachexia Sarcopenia Muscle. 2021 Mar 20;: